This guide offers a framework for categorising life sciences real estate into five types: R&D/Labs, Production, Distribution, Point of Care, and Mixed-Use/Flexible Facilities.
To maximise the value of their enormous real estate portfolios, pharma companies have two key strategies: continuous portfolio optimisation and capital unlocking through sale and leaseback (S&LB) transactions.